Logo image of MASS

908 DEVICES INC (MASS) Stock Fundamental Analysis

NASDAQ:MASS - Nasdaq - US65443P1021 - Common Stock - Currency: USD

5.0888  -0.64 (-11.19%)

Fundamental Rating

3

Taking everything into account, MASS scores 3 out of 10 in our fundamental rating. MASS was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. While MASS seems to be doing ok healthwise, there are quite some concerns on its profitability. MASS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MASS had negative earnings in the past year.
MASS had a negative operating cash flow in the past year.
In the past 5 years MASS always reported negative net income.
MASS had negative operating cash flow in 4 of the past 5 years.
MASS Yearly Net Income VS EBIT VS OCF VS FCFMASS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

MASS has a Return On Assets of -45.28%. This is amonst the worse of the industry: MASS underperforms 83.20% of its industry peers.
MASS has a Return On Equity of -63.01%. This is in the lower half of the industry: MASS underperforms 79.20% of its industry peers.
Industry RankSector Rank
ROA -45.28%
ROE -63.01%
ROIC N/A
ROA(3y)-25.68%
ROA(5y)-18.55%
ROE(3y)-34.2%
ROE(5y)-24.45%
ROIC(3y)N/A
ROIC(5y)N/A
MASS Yearly ROA, ROE, ROICMASS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

The Gross Margin of MASS (50.18%) is better than 86.40% of its industry peers.
In the last couple of years the Gross Margin of MASS has grown nicely.
MASS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.03%
GM growth 5Y2.07%
MASS Yearly Profit, Operating, Gross MarginsMASS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. Health

2.1 Basic Checks

MASS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MASS has been increased compared to 1 year ago.
Compared to 5 years ago, MASS has more shares outstanding
There is no outstanding debt for MASS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MASS Yearly Shares OutstandingMASS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MASS Yearly Total Debt VS Total AssetsMASS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

MASS has an Altman-Z score of 0.83. This is a bad value and indicates that MASS is not financially healthy and even has some risk of bankruptcy.
MASS's Altman-Z score of 0.83 is on the low side compared to the rest of the industry. MASS is outperformed by 70.40% of its industry peers.
There is no outstanding debt for MASS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACCN/A
WACC9.01%
MASS Yearly LT Debt VS Equity VS FCFMASS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 4.10 indicates that MASS has no problem at all paying its short term obligations.
The Current ratio of MASS (4.10) is better than 77.60% of its industry peers.
MASS has a Quick Ratio of 3.45. This indicates that MASS is financially healthy and has no problem in meeting its short term obligations.
MASS has a Quick ratio of 3.45. This is in the better half of the industry: MASS outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.1
Quick Ratio 3.45
MASS Yearly Current Assets VS Current LiabilitesMASS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

MASS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.65%.
The Revenue has grown by 18.71% in the past year. This is quite good.
MASS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.11% yearly.
EPS 1Y (TTM)-2.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-143.48%
Revenue 1Y (TTM)18.71%
Revenue growth 3Y12.21%
Revenue growth 5Y27.11%
Sales Q2Q%31.14%

3.2 Future

The Earnings Per Share is expected to grow by 14.44% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.08% on average over the next years.
EPS Next Y17.34%
EPS Next 2Y14.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.52%
Revenue Next 2Y7.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MASS Yearly Revenue VS EstimatesMASS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
MASS Yearly EPS VS EstimatesMASS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

MASS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MASS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MASS Price Earnings VS Forward Price EarningsMASS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MASS Per share dataMASS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as MASS's earnings are expected to grow with 14.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MASS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

908 DEVICES INC

NASDAQ:MASS (5/13/2025, 12:10:12 PM)

5.0888

-0.64 (-11.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-04 2025-03-04/bmo
Earnings (Next)05-13 2025-05-13/bmo
Inst Owners64.28%
Inst Owner Change1.86%
Ins Owners8.41%
Ins Owner Change1.61%
Market Cap181.87M
Analysts84
Price Target5.61 (10.24%)
Short Float %8.48%
Short Ratio0.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.6%
Min EPS beat(2)-58.68%
Max EPS beat(2)113.88%
EPS beat(4)3
Avg EPS beat(4)18.71%
Min EPS beat(4)-58.68%
Max EPS beat(4)113.88%
EPS beat(8)6
Avg EPS beat(8)15.73%
EPS beat(12)9
Avg EPS beat(12)10.66%
EPS beat(16)11
Avg EPS beat(16)7.16%
Revenue beat(2)1
Avg Revenue beat(2)1.15%
Min Revenue beat(2)-10.3%
Max Revenue beat(2)12.6%
Revenue beat(4)3
Avg Revenue beat(4)2.38%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)12.6%
Revenue beat(8)6
Avg Revenue beat(8)4.36%
Revenue beat(12)8
Avg Revenue beat(12)3.4%
Revenue beat(16)12
Avg Revenue beat(16)5.51%
PT rev (1m)0%
PT rev (3m)3.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.96%
EPS NY rev (1m)0%
EPS NY rev (3m)26.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-16.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.05
P/FCF N/A
P/OCF N/A
P/B 1.59
P/tB 2.62
EV/EBITDA N/A
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.96
Fwd EYN/A
FCF(TTM)-0.86
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS1.67
BVpS3.21
TBVpS1.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.28%
ROE -63.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.18%
FCFM N/A
ROA(3y)-25.68%
ROA(5y)-18.55%
ROE(3y)-34.2%
ROE(5y)-24.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.03%
GM growth 5Y2.07%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.86%
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.1
Quick Ratio 3.45
Altman-Z 0.83
F-Score3
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)75.32%
Cap/Depr(5y)61.35%
Cap/Sales(3y)3.15%
Cap/Sales(5y)2.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-143.48%
EPS Next Y17.34%
EPS Next 2Y14.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.71%
Revenue growth 3Y12.21%
Revenue growth 5Y27.11%
Sales Q2Q%31.14%
Revenue Next Year-3.52%
Revenue Next 2Y7.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.7%
OCF growth 3YN/A
OCF growth 5YN/A